Anvisa requires prescriptions for weight loss pens amid safety concerns

oglobo.globo.com (Portuguese)

Anvisa issued a warning about weight loss pens due to increased suspected adverse reactions, primarily pancreatitis. The agency requires prescriptions and monitoring, citing 145 suspected adverse events and six deaths in Brazil between 2020 and December 2025. The pens are popular for diabetes and obesity but require proper medical guidance and legal sourcing to mitigate risks.


With a significance score of 1.8, this news ranks in the top 27% of today's 29775 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: